Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes

Authors: A Sharma, C Wanner, A P Ofstad, M Mattheus, B J Kraus, B Zinman, J P Ferreira

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.1004

Source: Full article